More News
-
-
An Auspicious Start to the Year of the Rabbit: Fosun Sees Boom in Various Businesses During the Spring Festival Golden Week
2023-01-30During the Spring Festival Golden Week this year, benefiting from the recovery of domestic consumption, various operating indicators of the business segments like Happiness and Health of Fosun International Limited (“Fosun International” or the “Company”) (HKEX: 00656) surged, setting an auspicious start to the Year of the Rabbit.During the Spring Festiv
-
-
Fosun International’s 2021 Annual Report Wins Gold Award at the 2022 International ARC Awards
2023-01-27On 27 January 2023, winners of the 36th International ARC Awards were announced.The2021 annual report of Fosun International Limited (“Fosun International”or the“Company”, HKEX: 00656) won Gold Award in the“Traditional Annual Report”category of the 2022 International ARC Awards. The awardcommendsFosun International’s annual report for its distinctive theme, clear business
-
-
Fosun International Wins Platinum Award at The Asset ESG Corporate Awards 2022
2023-01-26(26 January 2023) Fosun International Limited (“Fosun International” or the “Company”) (HKEX: 00656) was informed byThe Asset, the renowned international asset management and investment magazine, that Fosun has garnered the Platinum Award at The Asset ESG Corporate Awards 2022.This year, Fosun International was accredited with the Platinum Award byThe Assetfor t
-
-
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties; COVID-19 Prevention and Treatment Live-Streaming Training for Rural Doctors Attracted over 1 Million Views
2023-01-21On January 16, the second stage of “A Healthy Winter Action” initiated by Fosun Foundation in conjunction with other institutions kicked off, with 19,600 bottles of Azvudine gradually shipped to the rural clinics of 24 counties across Sichuan, Chongqing, Gansu, Hainan, Yunnan, Guizhou and Jiangxi provinces. The drugs were donated together with the
-
-
COMIRNATY® Bivalent COVID-19 Vaccine is Officially Approved as Regular Imported Vaccine by the Pharmaceutical Administration Bureau of Macao SAR
2023-01-20(Shanghai, China, January 20, 2023) On January 20, 2023, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “Group”; Stock Code: 600196.SH, 02196.HK) announced that COMIRNATY®Original/Omicron BA.4/BA.5 bivalent COVID-19 vaccine (also known as COMIRNATY® Bivalent COVID-19 Vaccine) is officially approved as a regular imported vaccine by